Navigation Links
Celltex Therapeutics Corporation Expands Laboratory Operations And Adds Depth To Its Management Team
Date:8/2/2012

work to ensure the safety of health products."

Young joins Celltex from Pharmaceutical Product Development, Inc. in Middleton, Wisconsin, where she served as Associate Research Scientist. Formerly an Internal physician in the Department of Medicine at Wang-Jiang-Shan Hospital in Zhejiang, China, and a Visiting Scientist and Ph.D. in molecular biology and biochemistry at the Lund University, Sweden, Young has expertise in cell biology, molecular genetics and biochemistry. She has also co-authored publications on the development and optimization of laboratory assays, and cell sort and flow cytometry analysis.

Young received her medical degree from Zhejiang University School of Medicine. Zhejiang, China.  She received her doctoral degree from Lund University, Faculty of Medicine in Sweden.

"Stem cell banking is cutting edge technology in a field that holds great potential," noted Young. "Quality and safety are tantamount to the growth of this industry and I am excited to help Celltex provide stem cell banking and multiplication of the highest quality to its clients."

For more information on Celltex Therapeutics Corporation and its staff please visit www.CelltexBank.com.

About Celltex

Celltex Therapeutics Corporation is a leader in providing services for the rapidly expanding field of regenerative medicine. Specifically, Celltex purifies, multiplies, and stores adult adipose-derived mesenchymal stem cells and rigorously follows the standards of good manufacturing practices for human cell laboratories. Celltex's laboratory currently holds more than fourteen patents protecting methodology and quality control. The Celltex process ensures extracted adult stem cells are separated, multiplied and stored without any genetic alteration or exposure to chemicals and drugs.  Celltex is currently researching new methods and technology for banking and stem cell treatment therapies
'/>"/>

SOURCE Celltex Therapeutics Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Karyopharm Therapeutics announces the Publication of Two Preclinical Studies on the Activity of Selective Inhibitors of Nuclear Export (SINE) in Acute Myeloblastic Leukemia (AML)
2. Cell Therapeutics, Inc. (CTI) to Report Second Quarter Financial Results on August 1
3. United Therapeutics Corporation Reports Second Quarter 2012 Financial Results
4. Relmada Therapeutics Raises $3.0 Million In Initial Closing Of Series A Financing
5. United Therapeutics Corporation to Announce Second Quarter 2012 Financial Results Before Market Open on Thursday, July 26, 2012
6. Juventas Therapeutics Raises $22.2 Million Series B Financing
7. Silence Therapeutics Announces Subscription and Open Offer to Raise up to £5.7 Million
8. Nektar Therapeutics Announces Private Placement of $125 Million of Senior Secured Notes Due in 2017
9. Bio-Innovator Saneron CCEL Therapeutics Supports Cryo-Cell International Leadership and Board of Directors in Proxy Contest
10. Global Neuroendocrine Carcinoma Therapeutics Market To Reach $475m By 2019 - Report
11. United Therapeutics Announces Additional $100 Million Share Repurchase Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... Ltd. today released new data on changes in the ... outbreaks, the mean Ebola Reston gene Replikin Count (number ... 2002 was 1.1; the mean Replikin Count increased twofold ... thus predicting the current outbreaks in humans. ... be able to predict outbreaks (1).  For example, increases ...
(Date:7/30/2014)... 2014   Wyle has been named ... Mission Support Services (FILMSS) contract awarded by the ... terms of the contract, Wyle will provide mission ... Calif. In particular, Wyle will provide program and ... on the International Space Station and collaborative science ...
(Date:7/30/2014)... Vycom announces the addition of Thermax PVC ... Factory Mutual (FM) 4910 fire propagation and smoke generation ... process tools, fume hoods, furniture and cabinetry. These criteria ... wafers used in electronic chip manufacturing. , ... excellent workability and superior aesthetics. It is available in ...
(Date:7/30/2014)... , July 30, 2014 Researchers ... to interrogate biology, but such devices can do ... As such, researchers have looked to ... in vitro metabolic engineering to characterize – ... chip. New devices are envisioned to recreate animal ...
Breaking Biology Technology:Wyle Wins NASA's Fully Integrated Lifecycle Mission Support Services Contract 2Vycom Announces Flametec® Thermax PVC (FM4910 Listed) For a Variety of Clean Room Applications with Excellent Workability and Aesthetics 2UMD Researchers Bridge Gap between Microelectronics, Biological Systems 2UMD Researchers Bridge Gap between Microelectronics, Biological Systems 3UMD Researchers Bridge Gap between Microelectronics, Biological Systems 4
... ARBOR, Mich., Sept. 15 Assay Designs and ... to announce a,collaborative agreement for development of reagents ... expedite drug discovery and development,efforts for spinal muscular ... infants and toddlers. "Assay Designs is excited and ...
... Enobia Pharma, an emerging biotech,company focused on ... pre-clinical data demonstrating that its enzyme,replacement therapy ... that,have already been severely weakened by the ... Enobia,s product ENB-0040, significantly,increases survival and prevents ...
... 3SBio Inc. (Nasdaq:,SSRX), a leading China-based biotechnology company ... today,announced the results of the shareholder votes at ... September 12, 2008 (Friday) at 10:00 a.m.,(Beijing time)., ... Dr. Jing Lou,Liping Xu, Bin Huang, Lawrence S. ...
Cached Biology Technology:Assay Designs(TM), Inc. and the Spinal Muscular Atrophy Foundation Announce Collaboration To Accelerate the Discovery of New Therapeutics for Spinal Muscular Atrophy (SMA) 2Enobia Pharma Presents PreClinical Data Showing ENB-0040 Significantly Improved Survival and Healed Skeletal Manifestations of Severe Hypophosphatasia in Mice 2Enobia Pharma Presents PreClinical Data Showing ENB-0040 Significantly Improved Survival and Healed Skeletal Manifestations of Severe Hypophosphatasia in Mice 3
(Date:7/30/2014)... change on the world,s animal and plant species ... a new paper by a research team from ... other organizations. The authors claim that most of ... it comes to climate change. , While ... the "direct" threats of changing temperatures and precipitation ...
(Date:7/30/2014)... Life Sciences Institute (SALSI), a joint venture between The ... University of Texas Health Science Center at San Antonio, ... Program. The winners, Emily Boice from UTSA and Lei ... for their project titled, "Novel engineered ferritins for tracking ... Boice and Huang,s research is focused on finding a ...
(Date:7/30/2014)... Clemson University associate professor Andrew S. Mount, performed cutting-edge ... way for novel anti-fouling paint for ships and boats ... , The team,s findings, published in Nature ... barnacles that attaches to a wide variety of surfaces ... as an underwater heavy-duty adhesive. , "In previous research, ...
Breaking Biology News(10 mins):Conservation scientists asking wrong questions on climate change impacts on wildlife 2Study: Marine pest provides advances in maritime anti-fouling and biomedicine 2
... nation,s most enterprising researchers were named Pew Scholars ... Trusts today. The scholarships provide flexible funding to ... problems such as diabetes, autism, Parkinson,s disease, and ... of researchers who have gone on to become ...
... A recent study in the Journal of Forestry ... exposed to multiple forest threats. The tool uses a novel ... more concentrated relative to other areas, and identifies where multiple ... never been used before to describe forest threats, according to ...
... AmericanEHR Partners based on a survey of nearly 1,400 ... purposes than smartphones. "Mobile Usage in the Medical Space ... most common activity of physicians who use an electronic health ... and receiving emails." The second most frequent activity among tablet ...
Cached Biology News:From autism to diabetes to Parkinson's disease 2From autism to diabetes to Parkinson's disease 3Study helps managers identify regions with multiple threat potential, including wildfires 2Survey of physicians suggests tablets more useful than smartphones 2
... in refrigerators, freezers, or liquid nitrogen. Conveniently sized to ... color coding to project, user, lab, etc. Holes in ... air circulation. Supplied with 10 x 10 (11.6 mm ... dimensions: 13 x 13 x 5.1 cm H (5 ...
Sterile glass 5 mm beads that make spreading bacterial and yeast cultures easy. Can be washed, autoclaved and reused....
Recombinant Rhesus Monkey IFN-Alpha...
REGULATED IN DEVELOPMENT AND DNA DAMAGE RESPONSES 1,HIF-1 responsive RTP801...
Biology Products: